This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Dec;20(12):1710-1712.

doi: 10.1002/ejhf.1327. Epub 2018 Oct 17.

Growth differentiation factor-15 reveals the dark side of heart failure

Kai C Wollert¹

Affiliations

PMID: 30328666
DOI: 10.1002/ejhf.1327

Free article

Editorial

Growth differentiation factor-15 reveals the dark side of heart failure

Kai C Wollert. Eur J Heart Fail. 2018 Dec.

Free article

. 2018 Dec;20(12):1710-1712.

doi: 10.1002/ejhf.1327. Epub 2018 Oct 17.

Author

Kai C Wollert¹

Affiliation

¹ Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

PMID: 30328666
DOI: 10.1002/ejhf.1327

No abstract available

PubMed Disclaimer

Comment on

Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
Bouabdallaoui N, Claggett B, Zile MR, McMurray JJV, O'Meara E, Packer M, Prescott MF, Swedberg K, Solomon SD, Rouleau JL; PARADIGM-HF Investigators and Committees. Bouabdallaoui N, et al. Eur J Heart Fail. 2018 Dec;20(12):1701-1709. doi: 10.1002/ejhf.1301. Epub 2018 Sep 11. Eur J Heart Fail. 2018. PMID: 30204280 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information